| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 14.544 | 12.620 | 18.180 | 17.650 | 18.414 | 21.583 | 23.308 | 24.253 | 33.901 | 31.309 |
| Total Income - EUR | 14.544 | 12.620 | 18.180 | 17.650 | 18.414 | 21.583 | 23.308 | 24.256 | 33.901 | 31.309 |
| Total Expenses - EUR | 7.798 | 7.075 | 8.124 | 8.866 | 10.505 | 8.359 | 13.528 | 13.599 | 16.706 | 21.686 |
| Gross Profit/Loss - EUR | 6.746 | 5.544 | 10.055 | 8.784 | 7.909 | 13.224 | 9.780 | 10.657 | 17.195 | 9.623 |
| Net Profit/Loss - EUR | 6.310 | 5.206 | 9.510 | 8.488 | 7.725 | 13.008 | 9.575 | 10.446 | 16.874 | 9.316 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Ioroma Bioline Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 507 |
| Current Assets | 7.238 | 12.279 | 16.356 | 22.101 | 28.034 | 38.441 | 44.853 | 48.819 | 23.779 | 14.718 |
| Inventories | 643 | 304 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 63 | 434 | 815 | 1.278 | 2.188 | 2.399 |
| Cash | 6.595 | 11.975 | 16.356 | 22.101 | 27.971 | 38.007 | 44.038 | 47.542 | 21.591 | 12.320 |
| Shareholders Funds | 6.355 | 5.250 | 9.554 | 8.531 | 7.767 | 20.628 | 29.746 | 34.079 | 16.914 | 9.365 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 883 | 7.029 | 6.802 | 13.570 | 20.267 | 17.814 | 15.107 | 14.740 | 6.865 | 5.860 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6399 - 6399" | |||||||||
| CAEN Financial Year |
6399
|
|||||||||
Comments - Ioroma Bioline Srl